Xiaoyi Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiaoyi Zhou has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Xianzhao Wei
Department of Orthopaedic Surgery, Changhai Hospital, Shanghai, China
12 shared publications Xiaoyu Li
Department of Orthopedics Shanghai Changhai Hospital Shanghai China
6 shared publicationsChen Liu
Department of Orthopaedic Surgery, Changhai Hospital, Shanghai, China
4 shared publicationsKun Jiao
Department of Orthopaedic Surgery, Changhai Hospital, Shanghai, China
4 shared publicationsYajun Cheng
Department of Spinal Surgery, Changhai Hospital, Shanghai, China
4 shared publicationsZixiang Deng
Department of Orthopedics Shanghai Changhai Hospital Shanghai China
4 shared publications
Latest Publications
- Open Access
- 28 March 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (4) , e70849
Low‐Intensity Pulsed Ultrasound Promotes Spinal Cord Injury Recovery by Regulating Microglia‐Mediated Neuroinflammation
Background: Spinal cord injury is a severe central nervous system disorder with high morbidity and mortality, whose pathological process is divided into primary and secondary injury. The regulation of neuroinflammation is a critical link in secondary injury, forming a positive feedback loop involving microglia and peripheral immune cells. Low‐intensity pulsed ultrasound, a noninvasive physical therapy, exhibits significant potential in regulating inflammation and promoting microangiogenesis in orthopedics and nerve repair, providing new insights for intervening in the secondary pathological cascade of SCI. However, its therapeutic effects and underlying molecular mechanisms in SCI treatment have not been systematically and in‐depth explored. Methods: A total of 88 Sprague–Dawley rats were randomly divided into the sham operation group, SCI group, and SCI + LIPUS treatment group (nine subgroups with different parameter combinations) to establish a T10 segment SCI model. The SCI + LIPUS group received LIPUS intervention (20 min/day, 5 days/week) starting 1 day after modeling. Basso, Beattie, and Bresnahan locomotor scores were used to evaluate hindlimb motor function at multiple time points postoperatively. On Day 28, spinal cord samples were collected for hematoxylin–eosin staining and immunofluorescence staining to assess cavity area, microglial infiltration, and inflammatory microenvironment changes. In in vitro experiments, a lipopolysaccharide‐induced BV2 microglial polarization model was established, followed by LIPUS intervention. Cell Counting Kit‐8 assay, quantitative polymerase chain reaction, immunofluorescence staining, and Transwell co‐culture with HT22 neurons combined with Western blot were used to detect cell viability, inflammatory factor expression, and neuronal apoptosis. RNA sequencing and bioinformatics analysis (GO/KEGG enrichment, protein–protein interaction network construction) were conducted on spinal cord tissues from the SCI and SCI + LIPUS groups to screen differentially expressed genes and hub genes. Results: BBB scores showed that the SCI + LIPUS group (especially with the parameters of 180 mW/cm 2 and 1.5 MHz) exhibited significantly better hindlimb motor function than the SCI group from day 7 postoperatively, persisting until day 28 ( p < 0.05). HE and immunofluorescence staining indicated that LIPUS reduced spinal cord cavity area, inhibited microglial activation, promoted M2‐type microglial polarization, and alleviated secondary inflammation. In vitro experiments confirmed that LIPUS enhanced BV2 cell viability and proliferation, upregulated the expression of anti‐inflammatory factors (IL‐10, Arg‐1), downregulated pro‐inflammatory factors (IL‐6, TNF‐α), and suppressed HT22 neuron apoptosis by inhibiting inflammatory factor secretion from BV2 cells. RNA sequencing identified 67 DEGs (26 upregulated, 41 downregulated) between the SCI + LIPUS and SCI groups, enriched in immune defense, extracellular matrix remodeling, NOD‐like receptor, and IL‐17 signaling pathways. Hub genes including CXCR2 were identified, and CXCR2 downregulation was confirmed to be involved in LIPUS‐mediated anti‐inflammatory effects. Conclusion: LIPUS effectively alleviates neuroinflammation after SCI and promotes neurological function recovery by regulating microglia‐mediated neuroinflammation, whose mechanism is associated with the modulation of NOD‐like receptor, IL‐17 signaling pathways and the downregulation of hub genes such as CXCR2. This study provides a scientific basis for the clinical application of LIPUS in SCI treatment and a theoretical foundation for exploring multi‐modal therapeutic strategies combining LIPUS with other therapies.
- 28 March 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (4) , e70849
Open AccessLow‐Intensity Pulsed Ultrasound Promotes Spinal Cord Injury Recovery by Regulating Microglia‐Mediated Neuroinflammation
Background: Spinal cord injury is a severe central nervous system disorder with high morbidity and mortality, whose pathological process is divided into primary and secondary injury. The regulation of neuroinflammation is a critical link in secondary injury, forming a positive feedback loop involving microglia and peripheral immune cells. Low‐intensity pulsed ultrasound, a noninvasive physical therapy, exhibits significant potential in regulating inflammation and promoting microangiogenesis in orthopedics and nerve repair, providing new insights for intervening in the secondary pathological cascade of SCI. However, its therapeutic effects and underlying molecular mechanisms in SCI treatment have not been systematically and in‐depth explored. Methods: A total of 88 Sprague–Dawley rats were randomly divided into the sham operation group, SCI group, and SCI + LIPUS treatment group (nine subgroups with different parameter combinations) to establish a T10 segment SCI model. The SCI + LIPUS group received LIPUS intervention (20 min/day, 5 days/week) starting 1 day after modeling. Basso, Beattie, and Bresnahan locomotor scores were used to evaluate hindlimb motor function at multiple time points postoperatively. On Day 28, spinal cord samples were collected for hematoxylin–eosin staining and immunofluorescence staining to assess cavity area, microglial infiltration, and inflammatory microenvironment changes. In in vitro experiments, a lipopolysaccharide‐induced BV2 microglial polarization model was established, followed by LIPUS intervention. Cell Counting Kit‐8 assay, quantitative polymerase chain reaction, immunofluorescence staining, and Transwell co‐culture with HT22 neurons combined with Western blot were used to detect cell viability, inflammatory factor expression, and neuronal apoptosis. RNA sequencing and bioinformatics analysis (GO/KEGG enrichment, protein–protein interaction network construction) were conducted on spinal cord tissues from the SCI and SCI + LIPUS groups to screen differentially expressed genes and hub genes. Results: BBB scores showed that the SCI + LIPUS group (especially with the parameters of 180 mW/cm 2 and 1.5 MHz) exhibited significantly better hindlimb motor function than the SCI group from day 7 postoperatively, persisting until day 28 ( p < 0.05). HE and immunofluorescence staining indicated that LIPUS reduced spinal cord cavity area, inhibited microglial activation, promoted M2‐type microglial polarization, and alleviated secondary inflammation. In vitro experiments confirmed that LIPUS enhanced BV2 cell viability and proliferation, upregulated the expression of anti‐inflammatory factors (IL‐10, Arg‐1), downregulated pro‐inflammatory factors (IL‐6, TNF‐α), and suppressed HT22 neuron apoptosis by inhibiting inflammatory factor secretion from BV2 cells. RNA sequencing identified 67 DEGs (26 upregulated, 41 downregulated) between the SCI + LIPUS and SCI groups, enriched in immune defense, extracellular matrix remodeling, NOD‐like receptor, and IL‐17 signaling pathways. Hub genes including CXCR2 were identified, and CXCR2 downregulation was confirmed to be involved in LIPUS‐mediated anti‐inflammatory effects. Conclusion: LIPUS effectively alleviates neuroinflammation after SCI and promotes neurological function recovery by regulating microglia‐mediated neuroinflammation, whose mechanism is associated with the modulation of NOD‐like receptor, IL‐17 signaling pathways and the downregulation of hub genes such as CXCR2. This study provides a scientific basis for the clinical application of LIPUS in SCI treatment and a theoretical foundation for exploring multi‐modal therapeutic strategies combining LIPUS with other therapies.
- Open Access
- 24 March 2026
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 46 (1)
Research Progress on Spinal Cord Repair Based on Regulation of the Neuroregenerative Microenvironment
Spinal cord injury is a disease with no complete cure. It typically results in loss of motor and sensory functions below the level of the lesion, leading to significant physical and psychological disorders. After spinal cord injury, the microenvironmental balance at the site of injury is disrupted, creating complex conditions that are not conducive to nerve regeneration and recovery of spinal cord function, such as hemorrhage and ischemia, glial scar formation, and nerve demyelination. As our knowledge of the spinal cord microenvironment has expanded, researchers have determined that therapeutic strategies that modulate the microenvironment represent a significant and efficacious avenue of investigation. This review summarizes the characteristics of microenvironmental changes at various stages after spinal cord injury. Additionally, it discusses novel strategies developed recently based on regulating the microenvironment after spinal cord injury to promote recovery. The investigation of a long-acting, targeted, and multitemporal combination therapy strategy to repair spinal cord injuries shows promise in terms of its developmental potential. Graphical Abstract A schematic overview of changes of microenvironment components after SCI and strategies for reconstructing microenvironment. NISCI Non-traumatic spinal cord injury, SCI Spinal cord injuryTSCI Traumatic spinal cord injury. Created with biorender.com
- 24 March 2026
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 46 (1)
Open AccessResearch Progress on Spinal Cord Repair Based on Regulation of the Neuroregenerative Microenvironment
Spinal cord injury is a disease with no complete cure. It typically results in loss of motor and sensory functions below the level of the lesion, leading to significant physical and psychological disorders. After spinal cord injury, the microenvironmental balance at the site of injury is disrupted, creating complex conditions that are not conducive to nerve regeneration and recovery of spinal cord function, such as hemorrhage and ischemia, glial scar formation, and nerve demyelination. As our knowledge of the spinal cord microenvironment has expanded, researchers have determined that therapeutic strategies that modulate the microenvironment represent a significant and efficacious avenue of investigation. This review summarizes the characteristics of microenvironmental changes at various stages after spinal cord injury. Additionally, it discusses novel strategies developed recently based on regulating the microenvironment after spinal cord injury to promote recovery. The investigation of a long-acting, targeted, and multitemporal combination therapy strategy to repair spinal cord injuries shows promise in terms of its developmental potential. Graphical Abstract A schematic overview of changes of microenvironment components after SCI and strategies for reconstructing microenvironment. NISCI Non-traumatic spinal cord injury, SCI Spinal cord injuryTSCI Traumatic spinal cord injury. Created with biorender.com
- Open Access
- 19 August 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1655747
Development and evaluation of the low back pain questionnaire for personnel working on islands
Background: Low back pain (LBP) is a significant musculoskeletal disorder with multifactorial causes, affecting workforce productivity globally. Personnel working on islands face heightened LBP risk due to intensive training (e.g., heavy lifting, prolonged standing) and harsh environmental conditions (high temperature, humidity, solar radiation). Existing LBP questionnaires, such as the Roland-Morris Disability Questionnaire and Oswestry Disability Index, lack specificity for island personnel's unique challenges. This study aimed to develop and validate the Low Back Pain Questionnaire (LBPQ) tailored to this population, aligning with the biopsychosocial medical model.Methods: The LBPQ development followed a six-step process: conceptual definition, item generation, purification, dimension extraction, and reliability/validity testing. Through literature review, expert discussions, and interviews with 30 personnel working on islands, a 50-item initial scale was refined to 25 items across five dimensions: Pain Severity, Training, Daily Life, Psychological Impact, and Island Specificity. The final scale was administered to 600 personnel working on islands (experimental group) and 600 personnel working on land (control group). Reliability was assessed via Cronbach's α, while validity included factor analysis, convergent/discriminant validity tests, and correlation with the Visual Analog Scale (VAS) and Oswestry Disability Index (ODI).Results: The LBPQ demonstrated excellent reliability for personnel working on islands (Cronbach's α = 0.978) and good validity, with a KMO value of 0.967 and a cumulative variance contribution rate of 93.322%. Confirmatory factor analysis showed optimal model fit (χ2/df = 1.354, CFI = 0.997, RMSEA = 0.024). Convergent and discriminant validity were superior in the island group compared to the control group. Strong correlations were observed with VAS (r = 0.675) and ODI (r = 0.824), confirming alignment with established scales.Conclusion: The LBPQ is a reliable and valid tool for assessing LBP in personnel working on islands, addressing their unique environmental and occupational risks. It enhances clinical understanding of LBP severity and psychosocial impacts, enabling targeted prevention and intervention strategies. Future research should validate its applicability across diverse island environments and further refine its brevity.
- 19 August 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1655747
Open AccessDevelopment and evaluation of the low back pain questionnaire for personnel working on islands
Background: Low back pain (LBP) is a significant musculoskeletal disorder with multifactorial causes, affecting workforce productivity globally. Personnel working on islands face heightened LBP risk due to intensive training (e.g., heavy lifting, prolonged standing) and harsh environmental conditions (high temperature, humidity, solar radiation). Existing LBP questionnaires, such as the Roland-Morris Disability Questionnaire and Oswestry Disability Index, lack specificity for island personnel's unique challenges. This study aimed to develop and validate the Low Back Pain Questionnaire (LBPQ) tailored to this population, aligning with the biopsychosocial medical model.Methods: The LBPQ development followed a six-step process: conceptual definition, item generation, purification, dimension extraction, and reliability/validity testing. Through literature review, expert discussions, and interviews with 30 personnel working on islands, a 50-item initial scale was refined to 25 items across five dimensions: Pain Severity, Training, Daily Life, Psychological Impact, and Island Specificity. The final scale was administered to 600 personnel working on islands (experimental group) and 600 personnel working on land (control group). Reliability was assessed via Cronbach's α, while validity included factor analysis, convergent/discriminant validity tests, and correlation with the Visual Analog Scale (VAS) and Oswestry Disability Index (ODI).Results: The LBPQ demonstrated excellent reliability for personnel working on islands (Cronbach's α = 0.978) and good validity, with a KMO value of 0.967 and a cumulative variance contribution rate of 93.322%. Confirmatory factor analysis showed optimal model fit (χ2/df = 1.354, CFI = 0.997, RMSEA = 0.024). Convergent and discriminant validity were superior in the island group compared to the control group. Strong correlations were observed with VAS (r = 0.675) and ODI (r = 0.824), confirming alignment with established scales.Conclusion: The LBPQ is a reliable and valid tool for assessing LBP in personnel working on islands, addressing their unique environmental and occupational risks. It enhances clinical understanding of LBP severity and psychosocial impacts, enabling targeted prevention and intervention strategies. Future research should validate its applicability across diverse island environments and further refine its brevity.
- Open Access
- 4 May 2025
- Published by Springer Nature in Spinal Cord
- Vol. 63 (6) , 306-318
Identification of disulfidptosis-related genes and subgroups in spinal cord injury
Study Design Bioinformatics analysis and experimental validation study. Objectives To investigate the role and expression patterns of disulfidptosis-related genes in spinal cord injury (SCI), identify potential pivotal genes, and explore possible therapeutic targets. Setting Shanghai, China. Methods Data acquisition and pre-processing: Screened 27 disulfidptosis-related genes based on literature and downloaded RNA-sequencing data of ASCI patients from GEO database (GSE151371); Identification of differentially expressed genes (DEGs): Used R package “limma” for differential gene expression analysis between ASCI samples and normal controls; Evaluating immune cell infiltration: Employed ssGSEA algorithm and CIBERSORT to determine immune cell abundance; Identification and functional verification of key genes: Intersected disulfidptosis-related genes with DEGs, and used machine learning techniques (Random Forest, Lasso, Support Vector Machine) to identify hub genes. Validated hub genes expression by real-time PCR; Construction of a diagnostic model: Developed a backpropagation neural network clinical prediction model based on hub genes and clinical features, and evaluated its performance using ROC curve. 6. Subcluster analysis: Performed consensus cluster analysis of ASCI samples and hub genes, and used GSVA to elucidate functional differences between subgroups. Results Identified 7764 DEGs in ASCI, with GO and KEGG enrichment in inflammation and autophagy-related pathways; Found differences in immune cell infiltration between ASCI and control groups, and correlation between immune cells and DRGs; Determined seven hub genes (MYL6, NUBPL, CYFIP1, IQGAP1, FLNB, SLC7A11, CD2AP) through machine learning; Validated the expression of hub genes by qRT-PCR; Constructed a clinical diagnostic model with good predictive accuracy (overall dataset accuracy of 83.3%); Identified two subtypes of ASCI based on hub genes, with different immune infiltration and pathway activity. Conclusion Disulfidptosis is closely related to spinal cord injury. The identified hub genes and subtypes provide new insights for biomarker and therapeutic target research. The diagnostic model has potential for clinical application, but further studies are needed due to limitations such as small sample size. Sponsorship This study was supported in part by the project of Youth Scientific and Technological Talents of PLA (2020QN06125), Changhong Talent Project in First affiliated hospital of Navy Medical University (Wei Xianzhao) and Basic Medical Research Project in First affiliated hospital of Navy Medical University (2023PY17). I want to reiterate that there is no prior publication of figures or tables and no conflict of interest in the submission of this manuscript. The graphical abstract is divided into two parts. The upper section sequentially illustrates the occurrence of disulfidptosis and changes in the immune microenvironment in the human body after SCI. The lower section displays the construction of a diagnostic model for SCI through the detection of changes in disulfidptosis-related genes, combined with patient clinical information.
- 4 May 2025
- Published by Springer Nature in Spinal Cord
- Vol. 63 (6) , 306-318
Open AccessIdentification of disulfidptosis-related genes and subgroups in spinal cord injury
Study Design Bioinformatics analysis and experimental validation study. Objectives To investigate the role and expression patterns of disulfidptosis-related genes in spinal cord injury (SCI), identify potential pivotal genes, and explore possible therapeutic targets. Setting Shanghai, China. Methods Data acquisition and pre-processing: Screened 27 disulfidptosis-related genes based on literature and downloaded RNA-sequencing data of ASCI patients from GEO database (GSE151371); Identification of differentially expressed genes (DEGs): Used R package “limma” for differential gene expression analysis between ASCI samples and normal controls; Evaluating immune cell infiltration: Employed ssGSEA algorithm and CIBERSORT to determine immune cell abundance; Identification and functional verification of key genes: Intersected disulfidptosis-related genes with DEGs, and used machine learning techniques (Random Forest, Lasso, Support Vector Machine) to identify hub genes. Validated hub genes expression by real-time PCR; Construction of a diagnostic model: Developed a backpropagation neural network clinical prediction model based on hub genes and clinical features, and evaluated its performance using ROC curve. 6. Subcluster analysis: Performed consensus cluster analysis of ASCI samples and hub genes, and used GSVA to elucidate functional differences between subgroups. Results Identified 7764 DEGs in ASCI, with GO and KEGG enrichment in inflammation and autophagy-related pathways; Found differences in immune cell infiltration between ASCI and control groups, and correlation between immune cells and DRGs; Determined seven hub genes (MYL6, NUBPL, CYFIP1, IQGAP1, FLNB, SLC7A11, CD2AP) through machine learning; Validated the expression of hub genes by qRT-PCR; Constructed a clinical diagnostic model with good predictive accuracy (overall dataset accuracy of 83.3%); Identified two subtypes of ASCI based on hub genes, with different immune infiltration and pathway activity. Conclusion Disulfidptosis is closely related to spinal cord injury. The identified hub genes and subtypes provide new insights for biomarker and therapeutic target research. The diagnostic model has potential for clinical application, but further studies are needed due to limitations such as small sample size. Sponsorship This study was supported in part by the project of Youth Scientific and Technological Talents of PLA (2020QN06125), Changhong Talent Project in First affiliated hospital of Navy Medical University (Wei Xianzhao) and Basic Medical Research Project in First affiliated hospital of Navy Medical University (2023PY17). I want to reiterate that there is no prior publication of figures or tables and no conflict of interest in the submission of this manuscript. The graphical abstract is divided into two parts. The upper section sequentially illustrates the occurrence of disulfidptosis and changes in the immune microenvironment in the human body after SCI. The lower section displays the construction of a diagnostic model for SCI through the detection of changes in disulfidptosis-related genes, combined with patient clinical information.
- Open Access
- 25 February 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1-28
Revolutionizing the treatment of intervertebral disc degeneration: an approach based on molecular typing
Intervertebral disc degeneration (IVDD) is a significant cause of global disability, reducing labor productivity, increasing the burden on public health, and affecting socio-economic well-being. Currently, there is a lack of recognized clinical approaches for molecular classification and precision therapy. Chondrocyte differentiation and prognosis-related genes were extracted from single-cell RNA sequencing and multi-omics data in the Gene Expression Omnibus (GEO) database through chondrocyte trajectory analysis and non-parametric tests. Subsequently, a precise IVDD risk stratification system was developed using ConsensusClusterPlus analysis. The clinical significance of molecular typing was demonstrated through case–control trials involving IVDD patients. Specific inhibitors of molecular typing were predicted using the pRRophetic package in R language and then validated in vitro. A stratified model for IVDD, considering chondrocyte differentiation and demonstrating high clinical relevance, was developed using a set of 44 chondrocyte fate genes. Extensive analyses of multi-omics data confirmed the clinical relevance of this model, indicating that cases in the High Chondrocyte Scoring Classification (HCSC) group had the most favorable prognosis, whereas those in the Low Chondrocyte Scoring Classification (LCSC) group had the worst prognosis. Additionally, clinical case–control studies provided evidence of the utility of IVDD molecular typing in translational medicine. A gene expression-based molecular typing approach was used to create a matrix identifying potential inhibitors specific to each IVDD subtype. In vitro experiments revealed that gefitinib, a drug designed for LCSC, not only had protective effects on chondrocytes but also could induce the conversion of LCSC into the HCSC subgroup. Therefore, IVDD molecular typing played a critical role in assisting clinicians with risk stratification and enabling personalized treatment decisions. The results of the study have provided a comprehensive and clinically relevant molecular typing for IVDD, involving a precise stratification system that offers a new opportunity for customizing personalized treatments for IVDD.
- 25 February 2025
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1-28
Open AccessRevolutionizing the treatment of intervertebral disc degeneration: an approach based on molecular typing
Intervertebral disc degeneration (IVDD) is a significant cause of global disability, reducing labor productivity, increasing the burden on public health, and affecting socio-economic well-being. Currently, there is a lack of recognized clinical approaches for molecular classification and precision therapy. Chondrocyte differentiation and prognosis-related genes were extracted from single-cell RNA sequencing and multi-omics data in the Gene Expression Omnibus (GEO) database through chondrocyte trajectory analysis and non-parametric tests. Subsequently, a precise IVDD risk stratification system was developed using ConsensusClusterPlus analysis. The clinical significance of molecular typing was demonstrated through case–control trials involving IVDD patients. Specific inhibitors of molecular typing were predicted using the pRRophetic package in R language and then validated in vitro. A stratified model for IVDD, considering chondrocyte differentiation and demonstrating high clinical relevance, was developed using a set of 44 chondrocyte fate genes. Extensive analyses of multi-omics data confirmed the clinical relevance of this model, indicating that cases in the High Chondrocyte Scoring Classification (HCSC) group had the most favorable prognosis, whereas those in the Low Chondrocyte Scoring Classification (LCSC) group had the worst prognosis. Additionally, clinical case–control studies provided evidence of the utility of IVDD molecular typing in translational medicine. A gene expression-based molecular typing approach was used to create a matrix identifying potential inhibitors specific to each IVDD subtype. In vitro experiments revealed that gefitinib, a drug designed for LCSC, not only had protective effects on chondrocytes but also could induce the conversion of LCSC into the HCSC subgroup. Therefore, IVDD molecular typing played a critical role in assisting clinicians with risk stratification and enabling personalized treatment decisions. The results of the study have provided a comprehensive and clinically relevant molecular typing for IVDD, involving a precise stratification system that offers a new opportunity for customizing personalized treatments for IVDD.
- Open Access
- 3 February 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1532629
Bioprinted hydrogels in bone regeneration: a bibliometric analysis
Background: The application of bioprinted hydrogels in the field of bone regeneration is garnering increasing attention. The objective of this study is to provide a comprehensive overview of the current research status, hotspots and research directions in this field through bibliometric methods, and to predict the development trend of this field.Methods: A search was conducted on 27 December 2024, for papers published on the Web of Science from 2010 to 2025. We used the bibliometrix package in the software program R to analyze the retrieved data and VOSviewer and CiteSpace to visualize hotspots and research trends in bioprinted hydrogels for bone regeneration.Results: We identified and reviewed 684 articles published in this field between 2010 and 2025. A total of 811 institutions and 1,166 researchers from 41 countries/regions contributed to these publications. Among them, China led in terms of the number of articles published, single-country publications (SCP), and multi-country publications (MCP). Our bibliometric-based visualization analysis revealed that the mechanical properties and osteogenic differentiation capacity of biomaterials have been a focal research topic over the past decade, while emerging research has also concentrated on the in vitro fabrication of stem cells for bone regeneration and osteogenic differentiation, particularly the precise application of in situ stem cell-loaded bioprinted organoids.Conclusion: This study provides an in-depth analysis of the research trajectory in the application of bioprinted hydrogels for bone regeneration. The number of research papers in this field is increasing annually, and the main research hotspots include bone regeneration, 3D printing, scaffolds, and hydrogels. Future research directions may focus on gelatin, additive manufacturing, and growth factors. Additionally, international collaboration is essential to enhance the effectiveness of bioprinted hydrogels in bone regeneration applications.
- 3 February 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1532629
Open AccessBioprinted hydrogels in bone regeneration: a bibliometric analysis
Background: The application of bioprinted hydrogels in the field of bone regeneration is garnering increasing attention. The objective of this study is to provide a comprehensive overview of the current research status, hotspots and research directions in this field through bibliometric methods, and to predict the development trend of this field.Methods: A search was conducted on 27 December 2024, for papers published on the Web of Science from 2010 to 2025. We used the bibliometrix package in the software program R to analyze the retrieved data and VOSviewer and CiteSpace to visualize hotspots and research trends in bioprinted hydrogels for bone regeneration.Results: We identified and reviewed 684 articles published in this field between 2010 and 2025. A total of 811 institutions and 1,166 researchers from 41 countries/regions contributed to these publications. Among them, China led in terms of the number of articles published, single-country publications (SCP), and multi-country publications (MCP). Our bibliometric-based visualization analysis revealed that the mechanical properties and osteogenic differentiation capacity of biomaterials have been a focal research topic over the past decade, while emerging research has also concentrated on the in vitro fabrication of stem cells for bone regeneration and osteogenic differentiation, particularly the precise application of in situ stem cell-loaded bioprinted organoids.Conclusion: This study provides an in-depth analysis of the research trajectory in the application of bioprinted hydrogels for bone regeneration. The number of research papers in this field is increasing annually, and the main research hotspots include bone regeneration, 3D printing, scaffolds, and hydrogels. Future research directions may focus on gelatin, additive manufacturing, and growth factors. Additionally, international collaboration is essential to enhance the effectiveness of bioprinted hydrogels in bone regeneration applications.
- Open Access
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
Changes in Nucleus Pulposus Cell Atlas and the Role of SPP1 During Intervertebral Disc Degeneration: Single‐Cell Sequencing Analysis
Background: The nucleus pulposus (NP) plays a central role in the pathogenesis of intervertebral disc degeneration (IVDD); however, its internal cellular heterogeneity and molecular mechanisms have not yet been elucidated. Methods: ScRNA‐seq was used to evaluate the structure of the NP at different degenerative stages in the same individual with IVDD. Unsupervised clustering of cells based on gene expression profiles was performed using the Seurat package and passed to uniform manifold approximation and projection (UMAP) for cluster visualization. A rat disc degeneration model and an in vitro human NP cell degeneration model were established to validate the scRNA‐seq identification results. Results: Six NP subclusters and immune cells were identified and their distribution and functional differences between healthy and degenerative states were investigated. Immune cells were present only in degenerated NPs and may trigger NP degeneration. Cellular communication within the NP was altered by the intervention of immune cells. Secreted phosphorylated protein 1 (SPP1), secreted by immune cells, plays a major role and is a key molecule in NP degeneration. The results of in vivo animal experiments and in vitro cellular experiments showed that the expression of SPP1 was increased in degenerating NPs. High expression of SPP1 promoted NP degeneration, whereas inhibition of its expression attenuated degeneration. Conclusions: Cytoarchitectural changes in NP were revealed by scRNA‐seq. SPP1 is involved in the pathogenesis of disc degeneration and may be a new target for intervention in IVDD.
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
Open AccessChanges in Nucleus Pulposus Cell Atlas and the Role of SPP1 During Intervertebral Disc Degeneration: Single‐Cell Sequencing Analysis
Background: The nucleus pulposus (NP) plays a central role in the pathogenesis of intervertebral disc degeneration (IVDD); however, its internal cellular heterogeneity and molecular mechanisms have not yet been elucidated. Methods: ScRNA‐seq was used to evaluate the structure of the NP at different degenerative stages in the same individual with IVDD. Unsupervised clustering of cells based on gene expression profiles was performed using the Seurat package and passed to uniform manifold approximation and projection (UMAP) for cluster visualization. A rat disc degeneration model and an in vitro human NP cell degeneration model were established to validate the scRNA‐seq identification results. Results: Six NP subclusters and immune cells were identified and their distribution and functional differences between healthy and degenerative states were investigated. Immune cells were present only in degenerated NPs and may trigger NP degeneration. Cellular communication within the NP was altered by the intervention of immune cells. Secreted phosphorylated protein 1 (SPP1), secreted by immune cells, plays a major role and is a key molecule in NP degeneration. The results of in vivo animal experiments and in vitro cellular experiments showed that the expression of SPP1 was increased in degenerating NPs. High expression of SPP1 promoted NP degeneration, whereas inhibition of its expression attenuated degeneration. Conclusions: Cytoarchitectural changes in NP were revealed by scRNA‐seq. SPP1 is involved in the pathogenesis of disc degeneration and may be a new target for intervention in IVDD.
- Open Access
- 3 October 2024
- Published by Springer Nature in Spinal Cord
- Vol. 62 (11) , 609-618
Bibliometric analysis of the inflammation expression after spinal cord injury: current research status and emerging frontiers
Study design: Bibliometric analysis. Objective: To analyze literature on inflammatory expression following spinal cord injury, highlighting development trends, current research status, and potential emerging frontiers. Setting: Not applicable. Methods: Articles were retrieved using terms related to spinal cord injury and inflammatory responses from the Web of Science Core Collection, covering January 1, 1980, to May 23, 2024. Tools like CiteSpace and VOSviewer assessed the research landscape, evaluating core authors, journals, and contributing countries. Keyword co-occurrence analyses identified research trends. Results: A total of 2504 articles were retrieved, showing a consistent increase in publications. The Journal of Neurotrauma had the highest publication volume and influence. The most prolific author was Cuzzocrea S, with Popovich PG having the highest H-index. China led in the number of publications, followed closely by the United States, which had the highest impact and extensive international collaboration. Research mainly focused on nerve function recovery, glial scar formation, and oxidative stress. Future research is expected to investigate cellular autophagy, vesicular transport, and related signaling pathways. Conclusion: The growing interest in inflammation caused by spinal cord injury is evident, with current research focusing on oxidative stress, glial scar, and neurological recovery. Future directions include exploring autophagy and extracellular vesicles for new therapies. Interdisciplinary research and extensive clinical trials are essential for validating new treatments. Biomarker discovery is crucial for diagnosis and monitoring, while understanding autophagy and signaling pathways is vital for drug development. Global cooperation is needed to accelerate the application of scientific findings, improving spinal cord injury treatment.
- 3 October 2024
- Published by Springer Nature in Spinal Cord
- Vol. 62 (11) , 609-618
Open AccessBibliometric analysis of the inflammation expression after spinal cord injury: current research status and emerging frontiers
Study design: Bibliometric analysis. Objective: To analyze literature on inflammatory expression following spinal cord injury, highlighting development trends, current research status, and potential emerging frontiers. Setting: Not applicable. Methods: Articles were retrieved using terms related to spinal cord injury and inflammatory responses from the Web of Science Core Collection, covering January 1, 1980, to May 23, 2024. Tools like CiteSpace and VOSviewer assessed the research landscape, evaluating core authors, journals, and contributing countries. Keyword co-occurrence analyses identified research trends. Results: A total of 2504 articles were retrieved, showing a consistent increase in publications. The Journal of Neurotrauma had the highest publication volume and influence. The most prolific author was Cuzzocrea S, with Popovich PG having the highest H-index. China led in the number of publications, followed closely by the United States, which had the highest impact and extensive international collaboration. Research mainly focused on nerve function recovery, glial scar formation, and oxidative stress. Future research is expected to investigate cellular autophagy, vesicular transport, and related signaling pathways. Conclusion: The growing interest in inflammation caused by spinal cord injury is evident, with current research focusing on oxidative stress, glial scar, and neurological recovery. Future directions include exploring autophagy and extracellular vesicles for new therapies. Interdisciplinary research and extensive clinical trials are essential for validating new treatments. Biomarker discovery is crucial for diagnosis and monitoring, while understanding autophagy and signaling pathways is vital for drug development. Global cooperation is needed to accelerate the application of scientific findings, improving spinal cord injury treatment.
- Open Access
- 29 August 2022
- Published by Wolters Kluwer Health in Spine
- Vol. 48 (1) , E14-E19
Measurement Properties of the Simplified Chinese Version of the Lumbar Spine Instability Questionnaire for Patients With Low Back Pain in Mainland China
Study Design.: A prospective study. Objective.: To develop a simplified Chinese version of Lumbar Spine Instability Questionnaire (SC-LSIQ) and test its measurement properties. Summary of Background Data.: The LSIQ has been translated into several languages. Different versions of LSIQ have proved good reliability and validity in evaluating patients with low back pain. However, there is no simplified Chinese version of LSIQ (SC-LSIQ). Materials and Methods.: The SC-LSIQ has been translated into a simplified Chinese version according to a standard procedure. A total of 155 patients with low back pain completed the SC-LSIQ along with Oswestry Disability Index, Roland-Morris disability questionnaire, Tampa Scale for Kinesiophobia, and visual analogue scale (VAS). The internal consistency, test-retest reliability, and validity of SC-LSIQ were then calculated to evaluate the measurement properties of SC-LSIQ. Results.: The results of SC-LSIQ demonstrated that there was no ceiling or floor effect detected. The Cronbach α coefficient of 0.911 determined a well internal consistency. The intraclass correlation coefficient (0.98) presented an excellent reliability of SC-LSIQ. The Pearson correlation coefficient (r) showed that the SC-LSIQ was excellent correlated to Oswestry Disability Index (r=0.809), Roland-Morris disability questionnaire (r=0.870), and Tampa Scale for Kinesiophobia (r=0.945,). Furthermore, it moderately correlated to visual analogue scale (r=0.586). Conclusion.: The SC-LSIQ features good internal consistency, reliability, and validity for evaluating Chinese patients with LBP. Results suggest that the SC-LSIQ can be appropriately applied to patients with LBP in routine clinical practice.
- 29 August 2022
- Published by Wolters Kluwer Health in Spine
- Vol. 48 (1) , E14-E19
Open AccessMeasurement Properties of the Simplified Chinese Version of the Lumbar Spine Instability Questionnaire for Patients With Low Back Pain in Mainland China
Study Design.: A prospective study. Objective.: To develop a simplified Chinese version of Lumbar Spine Instability Questionnaire (SC-LSIQ) and test its measurement properties. Summary of Background Data.: The LSIQ has been translated into several languages. Different versions of LSIQ have proved good reliability and validity in evaluating patients with low back pain. However, there is no simplified Chinese version of LSIQ (SC-LSIQ). Materials and Methods.: The SC-LSIQ has been translated into a simplified Chinese version according to a standard procedure. A total of 155 patients with low back pain completed the SC-LSIQ along with Oswestry Disability Index, Roland-Morris disability questionnaire, Tampa Scale for Kinesiophobia, and visual analogue scale (VAS). The internal consistency, test-retest reliability, and validity of SC-LSIQ were then calculated to evaluate the measurement properties of SC-LSIQ. Results.: The results of SC-LSIQ demonstrated that there was no ceiling or floor effect detected. The Cronbach α coefficient of 0.911 determined a well internal consistency. The intraclass correlation coefficient (0.98) presented an excellent reliability of SC-LSIQ. The Pearson correlation coefficient (r) showed that the SC-LSIQ was excellent correlated to Oswestry Disability Index (r=0.809), Roland-Morris disability questionnaire (r=0.870), and Tampa Scale for Kinesiophobia (r=0.945,). Furthermore, it moderately correlated to visual analogue scale (r=0.586). Conclusion.: The SC-LSIQ features good internal consistency, reliability, and validity for evaluating Chinese patients with LBP. Results suggest that the SC-LSIQ can be appropriately applied to patients with LBP in routine clinical practice.
- Open Access
- 8 September 2021
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 19 (1) , 1-20
Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury
Background: Spinal cord injury (SCI) is an inflammatory condition, and excessive adenosine triphosphate (ATP) is released into the extracellular space, which can be catabolized into adenosine by CD73. Extracellular vesicles have been designed as nano drug carriers in many diseases. However, their impacts on delivery of CD73 after SCI are not yet known. We aimed to construct CD73 modified extracellular vesicles and explore the anti-inflammatory effects after SCI. Methods: CD73 engineered extracellular vesicles (CD73+ hucMSC-EVs) were firstly established, which were derived from human umbilical cord mesenchymal stem cells (hucMSCs) transduced by lentiviral vectors to upregulate the expression of CD73. Effects of CD73+ hucMSC-EVs on hydrolyzing ATP into adenosine were detected. The polarization of M2/M1 was verified by immunofluorescence. Furthermore, A2aR and A2bR inhibitors and A2bR knockdown cells were used to investigate the activated adenosine receptor. Biomarkers of microglia and levels of cAMP/PKA were also detected. Repetitively in vivo study, morphology staining, flow cytometry, cytokine analysis, and ELISA assay, were also applied for verifications. Results: CD73+ hucMSC-EVs reduced concentration of ATP and promoted the level of adenosine. In vitro experiments, CD73+ hucMSC-EVs increased macrophages/microglia M2:M1 polarization, activated adenosine 2b receptor (A2bR), and then promoted cAMP/PKA signaling pathway. In mice using model of thoracic spinal cord contusion injury, CD73+ hucMSC-EVs improved the functional recovery after SCI through decreasing the content of ATP in cerebrospinal fluid and improving the polarization from M1 to M2 phenotype. Thus, the cascaded pro-inflammatory cytokines were downregulated, such as TNF-α, IL-1β, and IL-6, while the anti-inflammatory cytokines were upregulated, such as IL-10 and IL-4. Conclusions: CD73+ hucMSC-EVs ameliorated inflammation after spinal cord injury by reducing extracellular ATP, promoting A2bR/cAMP/PKA pathway and M2/M1 polarization. CD73+ hucMSC-EVs might be promising nano drugs for clinical application in SCI therapy. Graphical
- 8 September 2021
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 19 (1) , 1-20
Open AccessExtracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury
Background: Spinal cord injury (SCI) is an inflammatory condition, and excessive adenosine triphosphate (ATP) is released into the extracellular space, which can be catabolized into adenosine by CD73. Extracellular vesicles have been designed as nano drug carriers in many diseases. However, their impacts on delivery of CD73 after SCI are not yet known. We aimed to construct CD73 modified extracellular vesicles and explore the anti-inflammatory effects after SCI. Methods: CD73 engineered extracellular vesicles (CD73+ hucMSC-EVs) were firstly established, which were derived from human umbilical cord mesenchymal stem cells (hucMSCs) transduced by lentiviral vectors to upregulate the expression of CD73. Effects of CD73+ hucMSC-EVs on hydrolyzing ATP into adenosine were detected. The polarization of M2/M1 was verified by immunofluorescence. Furthermore, A2aR and A2bR inhibitors and A2bR knockdown cells were used to investigate the activated adenosine receptor. Biomarkers of microglia and levels of cAMP/PKA were also detected. Repetitively in vivo study, morphology staining, flow cytometry, cytokine analysis, and ELISA assay, were also applied for verifications. Results: CD73+ hucMSC-EVs reduced concentration of ATP and promoted the level of adenosine. In vitro experiments, CD73+ hucMSC-EVs increased macrophages/microglia M2:M1 polarization, activated adenosine 2b receptor (A2bR), and then promoted cAMP/PKA signaling pathway. In mice using model of thoracic spinal cord contusion injury, CD73+ hucMSC-EVs improved the functional recovery after SCI through decreasing the content of ATP in cerebrospinal fluid and improving the polarization from M1 to M2 phenotype. Thus, the cascaded pro-inflammatory cytokines were downregulated, such as TNF-α, IL-1β, and IL-6, while the anti-inflammatory cytokines were upregulated, such as IL-10 and IL-4. Conclusions: CD73+ hucMSC-EVs ameliorated inflammation after spinal cord injury by reducing extracellular ATP, promoting A2bR/cAMP/PKA pathway and M2/M1 polarization. CD73+ hucMSC-EVs might be promising nano drugs for clinical application in SCI therapy. Graphical